Kunitz-Type Protease Inhibitor TFPI2 Remodels Stemness and Immunosuppressive Tumor Microenvironment in Glioblastoma

Scientists identified Kunitz-type protease inhibitor TFPI2 as a critical factor connecting these cell populations and their associated glioblastoma hallmarks of stemness and immunosuppression.